Prolonged molecular remission after PML/RARα-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: Is relevant pretransplant minimal residual disease in the graft?

Leukemia

Volumn 12, Issue 6, 1998, Pages 992-995

  Sanz, M A ^a   De La Rubia, J ^a   Bonanad, S ^a   Barragan E ^a   Sempere, A ^a   Martin G ^a   Martinez J A ^a   Jimenez C ^a   Cervera, J ^a   Bolufer, P ^a   Sanz, G F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

APL; Autologous PBSC transplantation; PML RAR

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYTARABINE; DAUNORUBICIN; PYRIMIDINE ANTAGONIST; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; HUMAN; LEUKAPHERESIS; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; ORAL DRUG ADMINISTRATION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION;

EID: 17144454734     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401024     Document Type: Article

References (19)

1. Warrell RP, de Thé H, Wang Z, Degos L. Acute promyelocytic leukemia. New Engl J Med 1993; 329: 177-189.
2. Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T, Pelicci PG. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 1992; 340: 1437-1438.
3. Miller WH Jr, Levine K, De Blasio A, Frankel SR, Dmitrovsky E, Warrell RP Jr. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction. Blood 1993; 82: 1689-1694.
4. Chang KS, Lu J, Wang G, Trujillo JM, Estey E, Cork A, Chu DT, Freireich EJ, Stass SA. The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene. Targets for the detection of minimal residual disease by polymerase chain reaction. Blood 1992; 79: 554-558.
5. Huang W, Sun G-L, Li X-S, Cao Q, Lu Y, Jang G-S, Zhang F-Q, Chai J-R, Wang Z-Y, Waxman S, Chen Z, Chen S-J. Acute promyelocytic leukemia: relevance of two major PML/RARα isoforms and detection of minimal residual disease by retrotranscriptase-polymerase chain reaction. Blood 1993; 82: 1264-1269.
6. Fukutani H, Naoe T, Ohno R, Yoshida H, Kiyoi H, Miyawaki S, Morishita H, Sano F, Kamibayashi H, Matsue K, Miyake T, Hasegawa S, Ueda Y, Kato Y, Kobayashi H, Shimazaki C, Kobayashi M, Kurane R, Sakota H, Masaki K, Wakayama T, Tohyama K, Nonaka Y, Natori H. Prognostic significance of the RT-PCR assay of PML/RARα transcripts in acute promyelocytic leukemia. Leukemia 1995; 9: 588-593.
7. Perego RA, Marenco P, Bianchi C, Cairoli R, Urnbano M, Nosari AM, Muti G, Morra E, Del Monte U. PML/RARα transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation. Leukemia 1996; 10: 207-212.
8. Frankel SR, Eardley A, Heller G, Berman E, Miller WH Jr. Dmitrovsky E, Warrell RP Jr. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann Int Med 1994; 120: 278-286.
9. Kanamura A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ohno R and the Japan Adult Leukemia Study Group. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 1995; 85: 1202-1206.
10. Lo Coco F, Diverio D, Avvisati G, Luciano A, Biondi A, Mandelli F. High frequency of early molecular remission in acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin. Blood 1995; 86 (Suppl. 1): 265a.
11. Avvsati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F. AIDA (All-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A GIMEMA pilot study. Blood 1996; 88: 1390-1398.
12. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz MA, Lowenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Ganser A, Jacky E, Dombret H, Chastang C, Degos L and the European ALP Group. Effect of all trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 1993; 82: 3241-3249.
13. Meloni G, Diverio D, Vignetti M, Avvisati G, Capria S, Petti MC, Mandelli F. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pre-transplant minimal residual disease assessment by reverse transcription polymerase chain reaction of the PML/RARα fusion gene. Blood 1997; 90: 1321-1325.
14. Chomczynsky P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-choroform extraction. Anal Biochem 1987; 162: 156-159.
15. Román J, Martin C, Torres A, Jiménez MA, Andrés P, Flores R, De la Torre MJ, Sánchez J, Serrano J, Falcón M. Absence of detectable PML/RARα fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia. Bone Marrow Transplant 1997; 17: 679-683.
16. Mandelli F, Labopin M, Granena A, Iriondo A, Prentice C, Bacigalupo A, Sierra J, Meloni G, Frassoni F, Goldman J, Gratwohl A, Gorin NC. European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Bone Marrow Transplant 1994; 14: 293-298.
17. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderson WF, Ihle JN. Gene marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 1993; 341: 85-86.
18. + autograft in acute promyelocytic leukemia. Eur J Haematol 1996; 55: 186-187.
19. Turhan AG, Lemoine FM, Debert C, Bonnet ML, Baillou C, Picard F, Macintyre EA, Varet B. Highly purified primitive hematopoietic stem cells are PML RAR-alpha negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood 1995; 85: 2154-2161.